Qualidade das evidências 4.88/5
Pontuação de revisão em oito dimensões segundo a grelha de qualidade . Cada dimensão pontuada de 1 a 5.
- D1 Ancoragem nas fontes
- 4/5
- D2 Autoridade das fontes
- 5/5
- D3 Aritmética
- 5/5
- D4 Incerteza
- 5/5
- D5 Âmbito
- 5/5
- D6 Prosa
- 5/5
- D7 Honestidade sobre a perceção
- 5/5
- D8 Completude das ressalvas
- 5/5
Como o risco varia
O valor principal é uma média de situações muito diferentes. Veja como a probabilidade varia por cenário ou contexto:
—
No epidemiological study has measured attributable disease from dietary or airborne microplastic exposure in the general US population. Exposure is real; harm is unquantified.
—
Workers in synthetic textile and plastics manufacturing have higher inhalation exposure. Some occupational studies report elevated respiratory symptoms (flock worker's lung), but these involve specific fiber types at industrial concentrations, not general microplastic exposure. Signal is weak and confounded by co-exposures.
—
Shellfish and small pelagic fish bioaccumulate microplastics. Consumers of large quantities of mussels, oysters, and sardines have higher ingestion estimates, but no cohort study has linked this dietary pattern to measurable health outcomes in humans.
—
Bottled water contains roughly 10-100x more microplastic particles per liter than tap water in most studies, likely from packaging. WHO's 2019 review found no health risk from either source at observed levels.
O comprimento e o tom da barra classificam estes cenários entre si, não em relação a outros riscos. As probabilidades exatas são mostradas ao lado de cada um.
A lacuna entre o medo e as evidências sobre microplásticos é ampla, mas segue uma direção incomum: o medo não é que a ciência diga que os microplásticos são seguros — é que a ciência ainda não diz nada de acionável. A revisão da OMS de 2019 sobre microplásticos na água potável encontrou “no reliable evidence” (nenhuma evidência confiável) de risco à saúde nos níveis de exposição atuais. A EFSA, após revisar mais de 100 estudos, não emitiu um valor de risco quantificado e não espera concluir sua opinião formal até o final de 2027. Nenhuma coorte epidemiológica mediu doenças humanas atribuíveis à exposição a microplásticos dietéticos ou transportados pelo ar em níveis de população geral. A entrada carrega no_reliable_estimate não porque o risco é conhecido por ser zero, mas porque ninguém o mediu bem o suficiente para atribuir um número a ele.
O que impulsiona o medo é uma heurística de detecção-igual-perigo. Leslie et al. (2022) encontraram partículas microplásticas em 77% das amostras de sangue humano — uma descoberta genuína e impressionante que prova a exposição sistêmica. Ragusa et al. as encontraram em placentas. Marfella et al. (2024), publicado no NEJM, relatou que pacientes com micro e nanoplásticos detectáveis na placa da artéria carótida tiveram uma taxa 4.5 vezes maior de eventos cardiovasculares do que aqueles sem. Mas a coorte de Marfella foi pré-selecionada (todos tinham doença carotídea assintomática que exigia cirurgia), o estudo carecia de controles anticontaminação no ambiente cirúrgico, e a associação em uma população doente não é causalidade no público em geral. Enquanto isso, a alegação de exposição de “um cartão de crédito por semana” que ancorou a percepção pública demonstrou superestimar a ingestão real em uma a duas ordens de magnitude — estimativas realistas ficam em torno de 0.01-0.1 gramas por semana, não 5 gramas.
O número ainda não existe, e isso importa mais do que qualquer substituto. A exposição ocupacional (trabalhadores têxteis e de plásticos inalando fibras sintéticas em concentrações industriais) tem uma base de evidências tênue, mas real, para efeitos respiratórios, embora confundida por coexposições. Consumidores pesados de frutos do mar ingerem mais partículas via bioacumulação em mariscos. A água engarrafada entrega aproximadamente 10-100x mais partículas por litro do que a água da torneira. Nenhum desses gradientes de exposição foi associado a resultados de saúde mensuráveis em humanos. O campo é pré-epidemiológico: sabemos que a exposição é universal, suspeitamos de plausibilidade biológica a partir de modelos animais e in vitro, e temos um estudo de associação provocativo, mas metodologicamente contestado. Isso não é nada, mas também não é uma probabilidade.
Curiosidades relacionadas
Os microplásticos aparecem no sangue, nos pulmões e nas placentas humanas, e a maioria dos adultos os coloca entre as principais preocupações de segurança alimentar. Mas a OMS não encontrou evidências confiáveis de que os microplásticos nos níveis atuais de exposição prejudiquem a saúde. Detectar não é o mesmo que um risco medido.
Registro de evidências
Cada número abaixo é o que cada fonte relatou, com a citação literal em que nos baseamos e como chegamos ao nosso valor. Clique em qualquer link para verificar diretamente.
1/7 fontes verificadas de forma independente palavra por palavra em relação à fonte citada
-
[1] World Health Organization — Microplastics in Drinking-Water
Microplastics in Drinking-WaterSee all 3 Likelier entries citing this source →
- Estatística
No reliable evidence that microplastics in drinking water at current exposure levels pose a risk to human health- Trecho
“"Based on the limited information we have, microplastics in drinking water don't appear to pose a health risk at current levels. But we need to find out more." ”
- Dados da fonte de
- 2019-08-22
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- WHO reviewed all available evidence on microplastic occurrence in drinking water (tap and bottled) and assessed potential health impacts from ingestion. The report concluded that particles larger than 150 micrometres are unlikely to be absorbed, uptake of smaller particles is expected to be limited, and no epidemiological data link drinking-water microplastic exposure to adverse health outcomes. WHO called for more research but did not identify a quantifiable risk, supporting the no_reliable_estimate classification.
- Independência
- WHO review synthesised global evidence independently of the Marfella, Leslie, and EFSA analyses cited below.
-
[2] New England Journal of Medicine / Marfella et al. — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events Verificado
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events- Estatística
Patients with detectable MNPs in carotid plaque had HR 4.53 (95% CI 2.00-10.27) for composite cardiovascular endpoint vs those without- Trecho
“"Patients in whom microplastics and nanoplastics were detected within the atheroma had a higher risk of a composite of myocardial infarction, stroke, or death from any cause than those in whom microplastics and nanoplastics were not detected." ”
- Dados da fonte de
- 2024-03-07
- Acessado
- 2026-04-18 · cópia arquivada
- Verificação
- Trecho obtido novamente de forma independente e confirmado palavra por palavra em relação à fonte citada durante nossa auditoria de fundamentação.
- Cálculo
- Marfella et al. prospectively followed 257 patients who underwent carotid endarterectomy and analyzed excised plaque for MNPs via pyrolysis-GC/MS. Polyethylene was detected in 58.4% of plaques (150 of 257); PVC in 12.1% (31 patients). After 34 months, the MNP-positive group had significantly higher cardiovascular events. However, this is an observational study in a high-risk surgical cohort (all had asymptomatic carotid disease), and critics note no pre-analytical anticontamination procedures were used — the surgical environment itself contains PE and PVC. The study demonstrates association in a diseased population, not causation in the general public, and cannot be converted to a population-level attributable risk.
- Independência
- Prospective clinical cohort study by Italian researchers using pyrolysis-GC/MS on excised plaque tissue; independent of WHO review and Leslie blood-detection study.
-
[3] Environment International / Leslie et al. — Discovery and quantification of plastic particle pollution in human blood
Discovery and quantification of plastic particle pollution in human blood- Estatística
Microplastics detected in 17 of 22 (77%) healthy adult blood samples at mean concentration of 1.6 µg/mL- Trecho
“"This is the first study to report quantitative data on plastic particle pollution in human blood, showing that plastic particles are bioavailable for uptake into the human bloodstream." ”
- Dados da fonte de
- 2022-03-24
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- Leslie et al. analyzed blood from 22 healthy Dutch volunteers using pyrolysis-GC/MS for five high-production polymers. PET was the most prevalent (50% of samples), followed by polystyrene (36%) and PE (23%). The study proves systemic exposure (detection) but does not measure health outcomes. No dose-response relationship, no disease endpoint, no follow-up. Detection of a substance in blood is a necessary but not sufficient condition for harm — the dose, persistence, and biological activity all remain unquantified for general-population microplastic exposure. This study is included because it is the most-cited driver of public fear, illustrating the detection-equals-danger heuristic.
- Independência
- Dutch laboratory study using independent pyrolysis-GC/MS methodology on volunteer blood samples; no overlap with the Marfella clinical cohort or WHO/EFSA reviews.
-
[4] Nature Medicine / Nihart et al. — Bioaccumulation of microplastics in decedent human brains
Bioaccumulation of microplastics in decedent human brains- Estatística
MNP concentration 7-30x higher in brain (median ~4900 µg/g) than liver/kidney; rose ~50% from 2016 to 2024; up to 10x higher in brains with documented dementia- Trecho
“"Concentrations in decedent brain samples were 7 to 30 times higher than in the liver or kidney... brain tissue from people who had been diagnosed with dementia had up to 10 times as much plastic in their brains as everyone else... the study design cannot show whether higher levels of plastic in the brain caused the dementia symptoms — they may simply accumulate more due to the disease process itself." ”
- Dados da fonte de
- 2025-02-03
- Acessado
- 2026-06-14 · cópia arquivada
- Cálculo
- Nihart et al. applied pyrolysis-GC/MS (corroborated by FTIR and electron microscopy) to >50 autopsy samples from the Albuquerque medical examiner, from decedents in 2016 and 2024. Brain MNP load (predominantly polyethylene, largely nanoscale shard-like fragments) far exceeded liver and kidney, and rose ~50% across the eight-year window. Brains with a documented dementia diagnosis showed up to 10x more plastic, concentrated in cerebrovascular walls and immune cells. This is a cross-sectional autopsy series: the dementia association is explicitly correlation, not causation, and the authors flag reverse causation (impaired clearance / blood-brain-barrier breakdown in dementia could increase deposition). It quantifies tissue burden and its temporal rise, not attributable disease risk, so it does not change the no_reliable_estimate classification.
- Independência
- US autopsy-tissue study using pyrolysis-GC/MS plus FTIR and electron microscopy; methodologically independent of the WHO review, the Marfella plaque cohort, the Leslie blood study, and the EFSA assessment.
-
[5] European Food Safety Authority — Microplastics and nanoplastics in food
Microplastics and nanoplastics in food- Estatística
EFSA risk assessment on microplastics in food scheduled for completion by end of 2027; no quantified health risk established as of 2025- Trecho
“"The European Parliament has requested EFSA to deliver a scientific opinion on the potential health risks posed by microplastics in food, water and air." ”
- Dados da fonte de
- 2025-10-28
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- EFSA's 2025 literature review of micro- and nanoplastic release from food contact materials analyzed over 100 studies (2015-2025) and concluded that while microplastic release from FCMs is real, current studies likely overestimate quantities, and nanoplastic data remain insufficient for reliable exposure estimates. EFSA has not issued a quantified risk figure. Their formal scientific opinion is not expected until end of 2027. The absence of an EFSA opinion after years of review is itself evidence of the epistemic gap — not of safety, but of insufficient data to quantify risk in either direction.
- Independência
- EFSA risk assessment is an independent EU regulatory review, methodologically separate from the WHO 2019 review and from individual primary studies.
-
[6] Journal of Hazardous Materials Letters / Pletz (2022) — Ingested Microplastics: Do Humans Eat One Credit Card per Week?
Ingested Microplastics: Do Humans Eat One Credit Card per Week?- Estatística
The widely cited 5g/week estimate overestimates ingestion by several orders of magnitude; realistic estimates are 0.01-0.1g/week- Trecho
“"Our analysis suggests that the widely reported figure of 5 g per week overestimates microplastic ingestion by several orders of magnitude." ”
- Dados da fonte de
- 2022-12-01
- Acessado
- 2026-04-18 · cópia arquivada
- Cálculo
- Pletz (2022) critically reviewed the Senathirajah et al. (2021) analysis that generated the "credit card per week" claim. The 5g figure was the extreme upper bound of a 0.1-5g range, and the underlying methodology conflated particle counts with mass in ways that inflate estimates. More careful analyses suggest typical adult ingestion is roughly 0.01-0.1g per week — still nonzero, but 50-500x lower than the headline figure. This matters because the perceived threat level is anchored to an exposure estimate that is almost certainly wrong by orders of magnitude.
- Independência
- Critical reanalysis of the WWF/Newcastle exposure estimate by independent food-science researchers; not affiliated with WHO, EFSA, or the original 2019 study authors.
-
[7] Environment International / Ragusa et al. — Plasticenta: First evidence of microplastics in human placenta
Plasticenta: First evidence of microplastics in human placenta- Estatística
12 microplastic fragments (5-10 micrometers) detected via Raman microspectroscopy in 4 of 6 human placentas from uneventful pregnancies- Trecho
“"In total, 12 microplastic fragments (ranging from 5 to 10 [micrometers] in size)...were found in 4 placentas." ”
- Dados da fonte de
- 2021-01-01
- Acessado
- 2026-07-03 · cópia arquivada
- Cálculo
- Substantiates the body prose's "Ragusa et al. found them in placentas" claim. First reported detection of microplastics in human placental tissue (fetal side, maternal side, and chorioamniotic membranes) in a small sample of six placentas from uneventful pregnancies. Like the Leslie blood study, this proves detection/bioavailability, not attributable health harm -- no outcome data, no dose-response, no disease endpoint measured. Does not change the no_reliable_estimate classification.
- Independência
- Italian clinical/laboratory study using Raman microspectroscopy on placental tissue; methodologically independent of the WHO review, the Marfella plaque cohort, the Leslie blood study, the Nihart brain study, and the EFSA assessment.